SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Cash B. D.)
 

Search: WFRF:(Cash B. D.) > Using florbetapir p...

  • Weston, P. S. J. (author)

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • 2015-11-02
  • Wiley,2015

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/229171
  • https://gup.ub.gu.se/publication/229171URI
  • https://doi.org/10.1016/j.dadm.2015.10.001DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Introduction: We aimed to assess the feasibility of determining Alzheimer's disease cerebrospinal fluid (CSF) cut points in small samples through comparison with amyloid positron emission tomography (PET). Methods: Twenty-three individuals (19 patients, four controls) had CSF measures of amyloid beta (Aβ)1-42 and total tau/Aβ1-42 ratio, and florbetapir PET. We compared CSF measures with visual and quantitative (standardized uptake value ratio [SUVR]) PET measures of amyloid. Results: Seventeen of 23 were amyloid-positive on visual reads, and 14 of 23 at an SUVR of ≥1.1. There was concordance (positive/negative on both measures) in 20 of 23, of whom 19 of 20 were correctly classified at an Aβ1-42 of 630 ng/L, and 20 of 20 on tau/Aβ1-42 ratio (positive ≥0.88; negative ≤0.34). Three discordant cases had Aβ1-42 levels between 403 and 729 ng/L and tau/Aβ1-42 ratios of 0.54-0.58. Discussion: Comparing amyloid PET and CSF biomarkers provides a means of assessing CSF cut points in vivo, and can be applied to small sample sizes. CSF tau/Aβ1-42 ratio appears robust at predicting amyloid status, although there are gray zones where there remains diagnostic uncertainty. © 2015 The Authors.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Paterson, R. W. (author)
  • Modat, M. (author)
  • Burgos, N. (author)
  • Cardoso, M. J. (author)
  • Magdalinou, N. (author)
  • Lehmann, M. (author)
  • Dickson, J. C. (author)
  • Barnes, A. (author)
  • Bomanji, J. B. (author)
  • Kayani, I. (author)
  • Cash, D. M. (author)
  • Ourselin, S. (author)
  • Toombs, J. (author)
  • Lunn, M. P. (author)
  • Mummery, C. J. (author)
  • Warren, J. D. (author)
  • Rossor, M. N. (author)
  • Fox, N. C. (author)
  • Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xzethe (author)
  • Schott, J. M. (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi (creator_code:org_t)

Related titles

  • In:Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring: Wiley1:4, s. 440-4462352-8729

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view